1. Protein kinase C protects from DNA damage-induced necrotic cell death by inhibiting poly(ADP-ribose) polymerase-1.
- Author
-
Hegedus C, Lakatos P, Oláh G, Tóth BI, Gergely S, Szabó E, Bíró T, Szabó C, and Virág L
- Subjects
- Animals, Apoptosis, Carbazoles pharmacology, Enzyme Activation, Indoles pharmacokinetics, Maleimides pharmacokinetics, Methylnitronitrosoguanidine pharmacology, Mice, Necrosis chemically induced, Necrosis genetics, Phorbol Esters pharmacology, Phosphorylation, Poly (ADP-Ribose) Polymerase-1, Protein Kinase C antagonists & inhibitors, Protein Kinase Inhibitors pharmacology, Thymus Gland cytology, Thymus Gland enzymology, Cytoprotection, DNA Damage, Necrosis enzymology, Poly(ADP-ribose) Polymerases metabolism, Protein Kinase C physiology
- Abstract
The goal of the current study, conducted in freshly isolated thymocytes was (1) to investigate the possibility that the activation of poly(ADP-ribose) polymerase-1 (PARP-1) in an intact cell can be regulated by protein kinase C (PKC) mediated phosphorylation and (2) to examine the consequence of this regulatory mechanism in the context of cell death induced by the genotoxic agent. In cells stimulated by the PKC activating phorbol esters, DNA breakage was unaffected, PARP-1 was phosphorylated, 1-methyl-3-nitro-1-nitrosoguanidine-induced PARP activation and cell necrosis were suppressed, with all these effects attenuated by the PKC inhibitors GF109203X or Gö6976. Inhibition of cellular PARP activity by PKC-mediated phosphorylation may provide a plausible mechanism for the previously observed cytoprotective effects of PKC activators.
- Published
- 2008
- Full Text
- View/download PDF